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Abstract
The innate immune system recognizes viral nucleic acids and stimulates cellular antiviral responses. Intracellular detection of
viral RNA is mediated by the Retinoic acid inducible gene (RIG)-I Like Receptor (RLR), leading to production of type I
interferon (IFN) and pro-inflammatory cytokines. Once cells are infected with a virus, RIG-I and MDA5 bind to viral RNA and
undergo conformational change to transmit a signal through direct interaction with downstream CARD-containing adaptor
protein, IFN-b promoter stimulator-1 (IPS-1, also referred as MAVS/VISA/Cardif). IPS-1 is composed of N-terminal Caspase
Activation and Recruitment Domain (CARD), proline-rich domain, intermediate domain, and C-terminal transmembrane (TM)
domain. The TM domain of IPS-1 anchors it to the mitochondrial outer membrane. It has been hypothesized that activated
RLR triggers the accumulation of IPS-1, which forms oligomer as a scaffold for downstream signal proteins. However, the
exact mechanisms of IPS-1-mediated signaling remain controversial. In this study, to reveal the details of IPS-1 signaling, we
used an artificial oligomerization system to induce oligomerization of IPS-1 in cells. Artificial oligomerization of IPS-1
activated antiviral signaling without a viral infection. Using this system, we investigated the domain-requirement of IPS-1 for
its signaling. We discovered that artificial oligomerization of IPS-1 could overcome the requirement of CARD and the TM
domain. Moreover, from deletion- and point-mutant analyses, the C-terminal Tumor necrosis factor Receptor-Associated
Factor (TRAF) binding motif of IPS-1 (aa. 453–460) present in the intermediate domain is critical for downstream signal
transduction. Our results suggest that IPS-1 oligomerization is essential for the formation of a multiprotein signaling
complex and enables downstream activation of transcription factors, Interferon Regulatory Factor 3 (IRF3) and Nuclear
Factor-kB (NF-kB), leading to type I IFN and pro-inflammatory cytokine production.
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Introduction
Viruses replicating within cells produce RNA with a non-self
signature, such as a double stranded (ds) and 59-triphosphate
structure, which are recognized by sensor molecules Retinoic acid
Inducible Gene-I (RIG-I), Melanoma Differentiation Associated
gene 5 (MDA5), and Laboratory of Genetics and Physiology 2
(LGP2), collectively known as RIG-I-Like Receptors (RLR)
[1,2,3,4]. RLR elicits signals to activate a set of genes including
those of type I and III interferon (IFN) to initiate innate antiviral
responses [5]. Several lines of evidence support a hypothesis that
once RIG-I and MDA5 recognize non-self RNA, conformational
changes are induced resulting in exposure of their CARD [6]. The
CARD of RIG-I and MDA5 transmits a signal to another CARD-
containing adaptor, Interferon Promoter Stimulator-1 (IPS-1, also
known as MAVS, VISA, and Cardif), which is anchored on the
outer membrane of the mitochondrion [7,8,9,10]. Cells infected
with a virus activate the RLR/IPS-1 signaling cascade and exhibit
microscopic aggregation of IPS-1 [11]. Activation of IPS-1 is
reconstituted in vitro and the formation of detergent-insoluble
IPS-1 aggregate has been reported [12]. For intracellular
aggregation of IPS-1, the involvement of mitofusin (MFN) 1,
which is known to regulate mitochondrial fusion, has been
reported [11], suggesting that IPS-1 aggregation is regulated
through a complex mechanism of mitochondrial dynamics. There
are several studies concerning how IPS-1 receives a signal from
RLR and how it relays it downstream; however, some of the
reports are not consistent with each other [10,13,14,15]. IPS-1
contains three potential TRAF binding motifs (TBMs) [10]. To
avoid confusion, we refer to them as TBM1 (aa. 143–147, human),
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TBM2 (aa. 154–159, human), and TBM3 (aa. 453–460, human).
TBM1 and 2 are close to each other (5 amino acids apart) and
reside within the proline-rich domain. TBM1 physically interacts
with TRAF3 [16] and a single amino acid substitution (T147I)
abolishes binding. Early reports demonstrated that an artificial
molecule essentially consisting of CARD and TM, therefore
devoid of TBMs (termed mini MAVS), is sufficient for signaling
[9,10,13]. In particular, TM can be replaced with that of other
mitochondrial proteins, suggesting the importance of its mito-
chondrial localization. Other reports have demonstrated that
artificial oligomerization of CARD of IPS-1 in the cytosol is
sufficient to activate the signal independent of the mitochondrion
[14].
In the current study, we aimed to delineate the inconsistencies
on the reported function of IPS-1 domains with a focus on the
oligomerization of IPS-1 and analyzed the necessary part of IPS-1
for signaling.
Results
Forced IPS-1 Oligomerization Activates Antiviral Innate
Immunity
Previously, we found that a virus-infection resulted in the
redistribution of IPS-1 to form speckle-like aggregates in cells [11].
Here, we attempted to demonstrate whether oligomerization of
IPS-1 was sufficient to induce antiviral signaling. To address this
question, we modified an artificial homodimerization system
(ARGENT Kit, ARIAD) [17]. We used 3 tandem repeats of
mutant FK 506 Binding Protein 12 (FKF36V), which can be cross-
linked by a cell-permeable chemical AP20187 (Figure 1A). FKF36V
harbors an F36V mutation, which impairs binding affinity to
immunosuppressive agent, FK506. AP20187 was designed specif-
ically for binding with FKF36V, so that it does not influence
endogenous FK binding proteins. Thus, this system specifically
crosslinks a target protein without the unwanted side effects. We
made constructs to artificially oligomerize CARD of RIG-I in cells
(FK-RIG CARD) [18] and IPS-1 (FK-IPS) (Figure 1A). HeLa cells
stably expressing 3xFKF36V (FK) and its fusion proteins were
treated with AP20187 and IFN-b mRNA levels were quantified.
AP20187 induced oligomerization of fusion proteins (Native
PAGE, data not shown). Oligomerization of FKF36V did not
induce IFN-bmRNA; however, FK-RIG CARD exhibited a rapid
induction of IFN-b mRNA (Figure 1B, [18]). Two independent
HeLa clones expressing FK-IPS activated the IFN-b gene upon
AP20187 treatment, both of which expressed the fusion protein
localized to mitochondria (data not shown). Furthermore,
AP20187 treatment induced speckle-like distribution of FK-IPS
in cells (data not shown). It is important to note that unlike
transient overexpression of IPS-1 in cell lines, which constitutively
activates the IFN-b gene; stable cells did not exhibit constitutive
IFN-b expression (Figure 1B). To confirm that this induction was
accompanied by activation of IRF-3, its dimer formation was
examined by native PAGE (Figure 1C). Consistent with IFN-b
mRNA levels, cells expressing FK-RIG and FK-IPS, but not FK
exhibited rapid IRF-3 dimer formation after exposure to
AP20187.
To further confirm the impact of antiviral signaling by this
artificial system, we examined expression profiles of interferon
stimulated genes by a DNA microarray of 237 immune-related
genes. 109 genes were transiently induced by IPS-1 oligomer (data
not shown). Representatives 11 genes, which are known to be
induced after a viral infection, are displayed in Figure 1D. Results
show that a simple oligomerization of FK-RIG CARD or FK-IPS
mimics the signaling induced by a viral infection (Figure 1D). In
contrast, only CARD of IPS-1 failed to induce any interferon or
cytokine gene expression in response to oligomerization (Figure
S1). From this, it would appear that the up-regulations of these
genes are not due to non-specific response induced by oligomer-
ized CARD-containing protein.
CARD of IPS-1 is Dispensable for Oligomerization-
induced Signaling
It has been hypothesized that upon activation of RIG-I, its
CARD is exposed by conformational changes and relays signaling
to IPS-1 through CARD-CARD interactions [8,9,10,19]. CARD
of IPS-1 is essential for signaling when IPS-1 is transiently over-
expressed [7,8]. We examined if CARD of IPS-1 was essential in
FK-IPS-mediated signaling. We constructed FK-IPS mutants: FK-
IPSDCARD, CARD deletion; FK-IPSCARD, FK fused to
CARD; FK-IPSTM, FK fused to TM, and FK-IPSDCARDDTM,
FK-IPS without CARD and TM, as summarized in Figure 2A.
Stable cells expressing FK-IPSDCARD showed little basal
activation of IRF-3; upon treatment with AP20187, strong
activation of IRF-3 was observed similar to that by FK-IPS
(Figure 2B). However, FK-IPS CARD did not activate IRF-3 even
after oligomerization (Figure 2B). Similarly, FK-IPSDCARD, but
not FK-IPSCARD did not induce IFN-b mRNA upon oligomer-
ization (Figure 2C). Oligomerization of FK on the mitochondrion
(FK-IPSTM) is not sufficient to activate IFN-b and Interleukin(IL)-
6 genes (Figure 2D, 2E). Interestingly, FK-IPSDCARDDTM,
which is localized in the cytoplasm (Figure S2) due to TM
deletions, activated IFN-b and IL-6 genes and formed speckle-like
aggregates upon oligomerization (Figure 2D, 2E, and Figure S2).
These results suggest that cytoplasmic oligomerization of an IPS-1
fragment (aa. 90–507), which includes TBM1–3, is sufficient for
signaling and mitochondrial localization is dispensable if forcibly
oligomerized.
Domain Delimitation of IPS-1 for IRF3 and NF-kB
Activation
To delimit the region of IPS-1 necessary to trigger signaling
upon oligomerization, we made a series of deletion mutants as
shown in Figure 3A. Stable clones of HeLa cells expressing these
mutants were mock treated or treated with AP20187 and nuclear
translocation of IRF-3 and NF-kB was determined by immuno-
staining (Figure 3B). Deletion of the proline-rich region (180–540)
showed little effect; however, further deletion of residues 400 to
464 abolished activation of both IRF-3 and NF-kB, indicating that
these residues are essential to signal. Quantitative analysis of IFN-
b and IL-6 gene expression revealed a significant attenuation of
signaling by the deletion of aa. 1–179 (Figure 3C, 3D), suggesting
the involvement of TBM1 and 2. This requirement of TBM1–2 is
more prominent for IL-6 gene expression. Importantly, further
deletion of aa. 400 to 464 (FKF36V-IPS 465–540), including
TBM3, resulted in the complete loss of signaling activity.
We also wondered whether MFN1 contributes to IPS-1
oligomerization because we previously reported that mitochon-
drial protein MFN1 promotes mitochondrial fusion and increases
signaling of IPS-1 [11]. We carried out a reporter assay with this
oligomerization system in MFN12/2 MEFs. MFN12/2 MEFs
showed comparable level of IFN-promoter activity to WT MEF
cells (Figure S3), suggesting that MFN1 is dispensable for signaling
induced by forced oligomerization of IPS-1.
Essential Role of TBM3 in Signaling
To further characterize functional residues within aa. 400–540,
we substituted a single amino acid within TBM3 (PEENEY to
Delimitation of Critical Domain in IPS-1
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PEDNEY: E457D) [10] to explore its significance (Figure 4A).
E457D substitution abolished gene activation of IFN-b and IL-6
with full-length or 400–540 FKF36V fusion constructs in stable
HeLa cells (Figure 4B, 4C). We confirmed that IRF and NF-kB
were activated by oligomerization of IPS-1 400–540 in a TBM3-
dependent manner (Figure 4D, 4E). We further mutagenized
TBM3 to resemble TBM of Toll/IL-1 receptor domain-contain-
ing adaptor inducing IFN-b (TRIF) (PEEMSW) or IL-1 receptor-
associated kinase (IRAK)-M (PVEDDE). As a negative control, the
motif was replaced to that of Myeloid Differentiation factor 88
(MyD88) (PSILRF), which does not bind directly to the TRAF
molecule [20]. Interestingly, substitution of TBM3 with TBM of
TRIF or IRAK-M restored the induction of IRF3 and NF-kB,
albeit with lower efficiency (Figure 4F, 4G). As expected, the
control motif of MyD88 failed to exhibit signaling. Furthermore,
we constructed FK-IPS 400–508, which retains TBM3 but lacks
the TM. This short fragment of IPS-1 also activated IRF-
responsive promoter upon oligomerization(Figure S4). This result
further supports the hypothesis that oligomerization of TBM3 is
essential in IPS-1 mediated signaling.
Viral Infection Induces Molecular Oligomer of IPS-1
The above results show that forced oligomerization of IPS-1
results in the activation of a signaling cascade. We investigated if a
viral infection induced oligomerization of IPS-1 using fusion
proteins of complementary fragments of a fluorescent reporter
protein (monomeric Kusabira-Green, mKG) [21]. Two split
inactive mKG fragments fused to IPS-1, respectively, were
expressed in cells. Fluorescence is expected to be detectable when
these IPS-1 fusions containing complementary mKG fragment
came into close vicinity (Figure 5A). 293T cells, which stably
expressed mKG-fusion IPS-1, were infected with Newcastle
disease virus (NDV) for 9h and then subjected to Fluorescence-
Activated Cell Sorting (FACS) analysis for the detection of
fluorescence. We observed enhanced fluorescence in NDV-
infected cells (Figure 5B), suggesting that viral infections induce
oligomer formation of IPS-1.
Discussion
Signaling initiated by cytoplasmic viral RNA sensors involves a
unique adaptor, IPS-1, which is specifically expressed on the outer
Figure 1. Forced IPS-1 oligomerization induced antiviral innate immune signaling. A. Schematic representation of FKBP fusion proteins
and their oligomerization by a cross-linker, AP20187. B. HeLa cells stably expressing indicated FKBP fusion proteins were treated with AP20187
(10 nM) for the indicated time. Cells were harvested and analyzed for IFN-b mRNA levels by qPCR. C. HeLa cells stably expressing indicated FKBP
fusion proteins were stimulated with AP20187 for 3 h and IRF-3 dimer formation was analyzed (Materials and Methods). Positions of the IRF-3
monomer and dimer are shown by arrowheads. D. Microarray analysis of mRNAs induced by oligomerized RIG-I CARD or IPS-1. Cells were stimulated
with AP20187 for the indicated time. Total RNA extracted from these cells was subjected to analysis using a DNA microarray (Genopal, Mitsubishi
Rayon) of interferon-stimulated genes and interferon genes. Relative mRNA levels using a control expression as 1.0 are shown. Representative data of
at least two independent experiments are shown.
doi:10.1371/journal.pone.0053578.g001
Delimitation of Critical Domain in IPS-1
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membrane of the mitochondrion. IPS-1 is a problematic protein,
since transient overexpression results in constitutive signaling,
whereas endogenous IPS-1 is tightly regulated by post-translation-
al mechanisms [22,23]. Here, we established a system to analyze
the regulation of IPS-1 by its oligomerization. We obtained stable
cell lines expressing FK-IPS fusion, which could be activated by a
crosslinker. Upon oligomerization, IPS-1 rapidly elicited signaling
leading to the activation of target genes including that of IFN-b,
suggesting that IPS-1 aggregation is essential and precedes possible
covalent modifications such as phosphorylation and ubiquitination
[24,25].
Our deletion analysis of FK-IPS-1 revealed that the TRAF
binding motif is essential while CARD is dispensable for
signaling. The initial report by Chen’s group reported that
CARD tethered to mitochondria-targeted TM (termed mini
MAVS) is sufficient to transduce signaling by its transient
overexpression [9,13]. They expressed mini-MAVS in cells
expressing endogenous IPS-1. However, when mini-MAVS was
expressed in IPS-12/2 cells, no signal was transduced (Figure
S5, [26]). And recently Chen’s group also reported that
depletion of endogenous IPS-1 by RNAi abrogated interferon
induction by mini-MAVS [12]. This can be interpreted as
transient overexpression of CARD in the vicinity of mitochon-
dria resulting in the aggregation of endogenous IPS-1. In
contrast, FK-IPS 400–450, which lacks CARD, is regulated by
oligomerization in IPS-12/2 MEFs (Figure 4D, 4E). Another
group showed that cytoplasmic oligomerization of CARD is
sufficient to activate signaling using FK fusion [14]. This result
is clearly inconsistent with ours (Figure 2B, 2C). They used wild
type FKBP12 and dimerizer chemical AP1510, which retains its
binding affinity to endogenous FKBP proteins. One of the
FKBPs, FKBP38 (also termed FKBP8) is known to associate
with the mitochondrial outer membrane [27]. Therefore, this
primordial oligomerization system may oligomerize the target
proteins (this case CARD) in association with mitochondria. We
used an improved FKBP system (ARGENT Kit, ARIAD),
which avoids this potential problem. On the other hand, FK-
IPS DCARDDTM, which contains TBMs, can activate signaling
upon oligomerization (Figure 2). This result highlights the fact
that cytoplasmic oligomerization of TBMs is sufficient for
signaling.
There are three potential TBMs within IPS-1 [10]. Our
result showing that FK-IPS 400–540 exhibited signaling in an
oligomerization-dependent manner (Figures 3 and 4) suggest
that oligomerization of TBM 3 alone is sufficient for signaling.
TBM3, initially identified as TRAF6 binding site [10], can also
recruit TRAF3 [28]. This is consistent with studies using
TRAF3 and TRAF6 knockout cells [29,30]. TBM1, 2, and 3
likely contribute to the signaling mediated by IPS-1, presumably
in a cooperative fashion and result in differential activation of
target genes. For example, TBM1 and 2 are dispensable for the
IFN-b gene, but IL-6 gene requires all TBM1, 2, and 3 for full
activation (Figure 3C, 3D). A recent report has shown that
CARD containing protein CARD9 is preferentially required for
Figure 2. CARD of IPS-1 is dispensable for oligomerization-induced signaling. A. Schematic representation of FK-IPS deletion mutants. B.
HeLa cells stably expressing indicated FK-IPS fusion were mock treated or treated with AP20187 for 3 h. Cell lysates were analyzed for IRF-3 dimer
formation as in Figure 1C. n.s.: non-specific band. C–E. Indicated HeLa cells stably expressing FK-IPS constructs were mock treated or treated with
AP20187 for 3 h. Cellular RNA were extracted and analyzed for IFN-b (C, D) or Il-6 (E) mRNA by qPCR. Representative data of at least two independent
experiments are shown. Error bars: standard error of triplicated samples.
doi:10.1371/journal.pone.0053578.g002
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PLOS ONE | www.plosone.org 4 January 2013 | Volume 8 | Issue 1 | e53578
proinflammatory cytokine induction downstream of RIG-I
signaling [31]. To explore the involvement of CARD9 in IPS-
1 mediated signaling, we knocked down CARD9 in a stable
HeLa clone expressing FK-IPS and examined its effect on the
activation of IFN-b and IL-6 genes (Figure S7). Although IFN-b
gene induction by oligomerization was little affected by reducing
CARD9, IL-6 gene activation was significantly attenuated.
Considering the result that IL-6 gene activation is more
dependent on TBM1/2 (Figure 3C, 3D), it is tempting to
speculate that TBM1/2 preferentially promote NF-kB activa-
tion, whereas TBM3 has a primary role of IRF-3/7
activation.Our results support a model that CARD of IPS-1
receives signaling from RLR via CARD-CARD interaction to
initiate oligomerization through mitochondrial dynamism; how-
ever, CARD of IPS-1 alone is not sufficient to trigger
downstream signaling. On the other hand, TBMs are essential
for further signaling by the recruitment of TRAF3 and 6, which
is initiated by molecular oligomerization. Consistent with this
model, we observed that artificial oligomerization of IPS-1
induced recruitment of TRAF6 into the NP-40-insoluble
fraction (Figure S6). Thus, IPS-1 receives and transmits




p-55C1BLuc, p-55A2Luc, p-125Luc, pRLtk, pEF-Bos-FLAG-
RIG-I CARD and pEF-Bos-FLAG-IPS-1 plasmids have been
described [11,32]. Expression plasmids of FKBP36v (oligomeriza-
tion peptide), pC4M-Fv2E, and pC4Fv1E were obtained from
ARIAD (ARGENT Regulated Homodimerization kit). We re-
constructed the vector, pC4Fv3E, which contains 3 tandem
repeats of FKBP36v [18]. To construct IPS-1 fused three tandem
FKBP, we amplified the IPS-1 sequence by PCR and inserted it
into the SpeI site of pC4Fv3E. Site-directed FK-fused IPS-1
mutants (FK-IPS E457D, FK-IPS 400–540 E457D) were
constructed using a KOD-Plus mutagenesis kit (TOYOBO,
Japan). Nucleotide sequences for these constructs were confirmed
with the BigDye DNA sequencing kit (Applied Biosystems).
Expression vectors encording Flag-MAVS and Flag-mini-MAVS
were obtained from Dr. Zhijian J. Chen.
Figure 3. Delimitation of critical domain in IPS-1 for IRF3 and NF-kB activation. A. Schematic representation of FK-IPS deletion mutants. B.
HeLa cells stably expressing indicated FK-IPS deletion mutants were mock treated or treated with AP20187 for 3 h. Cell were fixed and stained for IRF-
3 and NF-kB p65, respectively. Fluorescent microscopic images of IRF3 and NF-kB staining are shown (top). The percentage of cells with nuclear IRF-3
or NF-kB was determined by counting 100 cells (bottom). C, D. Cellular RNA was extracted and analyzed for IFN-b (C) or IL-6 (D) mRNA by qPCR.
Representative data of at least two independent experiments are shown. Error bars: standard error of triplicated samples. Statistical analyses were
conducted with an unpaired t test, with values of p,0.05 considered statistically significant. *p,0.05, **p,0.005.
doi:10.1371/journal.pone.0053578.g003
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Cell, DNA Transfection, and Preparation of Cell Extracts
HeLa, 293T cells [32,33] and Mouse embryonic fibroblasts
(MEFs) [5,34] were maintained in Dulbecco’s Modified Eagle’s
Medium with 10% fetal bovine serum and penicillin-streptomycin.
MEFs deficient for IPS-1 were obtained from Dr. S. Akira (Osaka
University). MEFs deficient in MFN1 were obtained from Dr.
David Chan (Caltech). HeLa, 293T cells, and MEFs were
transfected with FuGENE 6 (Roche Applied Science). Stable
transformants of HeLa cells were established by transfection of
linearized plasmids, encoding the FKBP construct and Puromycin
resistance gene, respectively, and cells were selected by Puromycin
(5 mg/ml). For preparation of cell extracts, cells were lysed with
lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM
EDTA, 1% Nonidet P-40, 0.1 mg/ml leupeptin, 1 mM phenyl-
methylsulfonyl fluoride, and 1 mM sodium orthovanadate) and
were centrifuged at 204006g for 10 min. The supernatant was
used for immunoblotting.
Viral Unfection
Cells were treated with culture medium or infected with NDV
at a MOI of 1 in serum-free and antibiotic-free medium. After
adsorption for 1 h at 37uC, the medium was changed and
infection was continued for 9 h in the precence of serum-
containing medium.
Reporter Assay
MEFs were transfected with firefly luciferase reporter (either p-
125 Luc, p-55C1BLuc or p-55A2Luc [32]) pRLtk (renilla
luciferase internal control) and effector expression plasmids. Cells
were split into three aliquots and were stimulated with chemical
dimerizer AP20187 (AP, 10 ng/ml in ethanol) or ethanol. The
luciferase assay was performed with a Dual-Luciferase reporter
assay system (Promega). Luciferase activity was normalized using
Renilla luciferase activity (pRLtk).
Quantitative Real Time PCR and Microarray Analysis
Total RNA was prepared with TRIZOL reagent (Invitrogen)
and treated with DNase I (Roche Diagnostics). A High-Capacity
Figure 4. Essential role of TBM3 in signaling. A. Schematic representation of FK-IPS fusion proteins. Asterisks represent the point mutation. B, C.
HeLa cells stably expressing indicated FK-IPS mutants were mock treated or treated with AP20187 for 3 h. Cellular RNA were extracted and analyzed
for IFN-b (B) or IL-6 (C) mRNA by qPCR. D–G. IPS-12/2 MEFs were transiently transfected with the luciferase reporter plasmid, p-55C1BLuc (for IRF, D,
F) or p-55A2Luc (for NF-kB, E, G), together with indicated FK-IPS-1 fusion constructs. For TBM3 mutants, substituted amino acids are shown as red
letters (F, G). Cells were treated with or without AP20187 for 6 h. Relative luciferase activities were determined as described in the Materials and
Methods. A representative result of at least two independent experiments is shown. Error bars: standard error of triplicated samples.
doi:10.1371/journal.pone.0053578.g004
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cDNA Reverse Transcription Kit (Applied Biosystems) was used
for cDNA synthesis and mRNA levels were monitored with the
Step One plus Real Time PCR system and TaqMan Fast
Universal PCR Master Mix (Applied Biosystems). TaqMan
primer-probes for human IFNB1, IL-6, IFNA8, and 18 s rRNA
were purchased from Applied Biosystems. RNA copy numbers
were normalized to that of an internal 18 s rRNA. In the
microarray analysis, we used the Genopal microarray system
according to the manufacturer’s instructions (Mitsubishi Rayon).
Biotin-labeled RNA was prepared with a MessageAmp II-Biotin
Enhanced kit (Ambion).
Immunoblotting and Antibodies
The polyclonal antibody used to detect human IRF-3 in native
PAGE and anti-human IRF-3 polyclonal antibodies for immuno-
staining were described previously [35]. Other antibodies were
obtained from the following sources: Anti-human NF-kB antibody
(sc-109), anti-human TRAF6 (sc-8409), and anti-human MFN1
(sc-50330) from Santa Cruz Biotechnology, anti-HA-Tag (6E2)
from Cell Signaling, and anti-human Actin (A-1978) from Sigma.
Immunofluorescence Microscopy
For immunofluorescence analysis, cells were fixed with 4%
paraformaldehyde for 10 min, permeabilized with acetone:
methanol (1:1), and blocked with 5 mg/ml of BSA in PBST
(0.04% Teen20 in PBS) for 1hour. Cells were incubated with
relevant primary antibodies overnight at 4uC, then incubated with
Alexa Fluor-conjugated secondary antibodies (Invitrogen). To
label mitochondria, cells were incubated for 30 min at 37uC with
MitoTracker Red CMXRos according to the manufacturer’s
instructions (Molecular Probes). Fluorescence images were ob-
tained by Leica Microsystems AF6500 (Leica).
RNA Interference
The siRNA negative control, targeting TRAF3 and TRAF6
were purchased from Bonac Corporation. The target sequences
were: (GCUCAUGGAUGCUGUGCAUdTdT) and (GGA-
GAAACCUGUUGUGAUUdTdT) for TRAF3 and 6, respec-
tively. Each siRNA was transfected with Lipofectamine 2000
(Invitrogen) according to the manufacturer’s instructions. At 48 h
post-transfection, cells were harvested, and then subjected to Real
Time PCR.
FACS
To examine oligomerization of IPS-1 in cells, we performed
bimolecular fluorescence complementation (BiFC) assays using a
CoralHue Fluo-Chase kit (Amalgam).
293T cells expressing this construct were washed and harvested
with PBS, then subjected to FACS analysis using FACSCanto II
(BD Bioscience).
Supporting Information
Figure S1 Microarray analysis of mRNAs induced by
oligomerized IPS-1 CARD or IPS-1. HeLa cells stably
expressing FK-IPS or FK-IPS CARD were stimulated with
AP20187 for the indicated time. Total RNA extracted from these
cells was subjected to analysis using a DNA microarray (Genopal,
Mitsubishi Rayon) of interferon-stimulated genes and interferon
genes. Relative mRNA levels using a control expression as 1.0 are
shown.
(PDF)
Figure S2 FK-IPS DCARDDTM forms speckle like
aggregates in the cytoplasm. HeLa cells stably expressing
FK-IPS DCARDDTM were mock treated or treated with
Figure 5. Viral infection induces the molecular oligomer of IPS-1. A. Schematic representation of dimers detection by mKG-tagged IPS-1. B.
Flow cytometry plots of control 293T cells and 2 clones stably expressing mKG-tagged IPS-1, #9 and #13. The cells were mock treated or infected
with NDV for 9 h. Cells exhibiting fluorescent intensity .101 were quantified and expressed as % of total cell number.
doi:10.1371/journal.pone.0053578.g005
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AP20187 for 3 h and stained with mitoTracker (mitochondria)
and anti-HA antibody. Fluorescent microscopic images of FK-
IPSDCARDDTM and mitochondria are shown.
(PDF)
Figure S3 MFN1 is dispensable for signaling induced by
forced oligomerization of IPS-1. MEFs of MFN12/2 or +/
+ were transiently transfected with p-125Luc (reporter for IFN-b
promoter activity) together with the indicated FK-IPS fusion
constructs. Cells were treated with or without AP20187 for 6 h.
Relative luciferase activities were determined as described in
Materials and Methods. A representative result of at least two
independent experiments is shown. Error bars indicate standard
error of triplicate samples.
(PDF)
Figure S4 FK-IPS 400–508 can activate IRF-responsive
promoter upon oligomerization. HEK 293T cells were
transiently transfected with p-55C1BLuc together with the FK or
FK-IPS 400–540 constructs. Cells were treated with or without
AP20187 for 6 h. Relative luciferase activities were determined as
described in Materials and Methods. A representative result of at
least two independent experiments is shown. Error bars indicate
standard error of triplicate samples.
(PDF)
Figure S5 IPS-1D100–500 (mini-MAVS) failed to activate
signaling in the absence of endogenous IPS-1. IPS-12/2
or +/+ MEFs were transiently transfected with luciferase reporter
plasmid, p-55C1BLuc together with IPS-1(MAVS), IPS-1D100–
500 (mini-MAVS), or control vector. Relative luciferase activities
were determined as described in Materials and Methods. A
representative result of at least two independent experiments is
shown. Error bars indicate standard error of triplicate samples.
(PDF)
Figure S6 Recruitment of TRAF6 into NP-40 insoluble
fraction upon oligomerization of IPS-1. A. Scheme for
isolation of soluble and insoluble fractions by differential
centrifugation. B and C. Immunoblot analysis of soluble/
insoluble fractions separated by differential centrifugation. FK-
IPS DCARD stable cells were cultured for 3 h in the absence or
presence of AP. Cell lysates were separated by differential
centrifugation. FK-IPS DCARD and endogenous MFN1, TRAF6,
and actin were detected by immunoblotting.
(PDF)
Figure S7 Involvement of CARD9 in NF-kB dependent
pathway. A. HeLa FK-IPS#48 cells were transfected with N.C.
siRNA or CARD9 targeted siRNA for 48 h, and the knockdown
of CARD9 was analyzed by RT-PCR. B, C and D. HeLa FK-
IPS#48 cells were transfected with N.C. siRNA or CARD9
targeted siRNA for 48 h, then mock treated or treated with
AP20187 for 3 h. Cellular RNA were extracted and analyzed for
IFN-b (B), Il-6 (C) or Il-1b (D) mRNA by qPCR. Representative
data of at least two independent experiments are shown. Error
bars: standard error of triplicated samples. Statistical analyses were
conducted with an unpaired t test, with values of p,0.05
considered statistically significant. *p,0.05.
(PDF)
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